These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 22282101

  • 41. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.
    D'Anna R, Cannata ML, Marini H, Atteritano M, Cancellieri F, Corrado F, Triolo O, Rizzo P, Russo S, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Adamo EB, Squadrito F.
    Menopause; 2009; 16(2):301-6. PubMed ID: 19034051
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L, Gass M, Constantine G, Olivier S, Study 315 Investigators.
    Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR.
    Menopause; 2008 Jan; 15(1):94-7. PubMed ID: 17882008
    [Abstract] [Full Text] [Related]

  • 46. Comparative efficacy and safety of estradiol transdermal preparations for the treatment of vasomotor symptoms in postmenopausal women: an indirect comparison meta-analysis.
    Derzko C, Sergerie M, Siliman G, Alberton M, Thorlund K.
    Menopause; 2016 Mar; 23(3):294-303. PubMed ID: 26382309
    [Abstract] [Full Text] [Related]

  • 47. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH.
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [Abstract] [Full Text] [Related]

  • 48. 0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes.
    Gerlinger C, Gude K, Schmelter T, Schaefers M, Endrikat J.
    Climacteric; 2015 Mar; 18(4):512-7. PubMed ID: 26000627
    [Abstract] [Full Text] [Related]

  • 49. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief.
    Panay N, Ylikorkala O, Archer DF, Gut R, Lang E.
    Climacteric; 2007 Apr; 10(2):120-31. PubMed ID: 17453860
    [Abstract] [Full Text] [Related]

  • 50. Randomized comparison of lower and standard dosages of transdermal estradiol on serum estradiol levels and vaginal maturation index.
    Rungruxsirivorn T, Panyakamlerd K, Trerattanachart S, Taechakraichana N.
    J Med Assoc Thai; 2006 Sep; 89(9):1362-7. PubMed ID: 17100370
    [Abstract] [Full Text] [Related]

  • 51. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.
    D'Anna R, Cannata ML, Atteritano M, Cancellieri F, Corrado F, Baviera G, Triolo O, Antico F, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Marini H, Squadrito F.
    Menopause; 2007 Sep; 14(4):648-55. PubMed ID: 17251874
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
    Bouchard P, Panay N, de Villiers TJ, Vincendon P, Bao W, Cheng RJ, Constantine G.
    Climacteric; 2012 Feb; 15(1):12-20. PubMed ID: 22066790
    [Abstract] [Full Text] [Related]

  • 55. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
    Notelovitz M, Cassel D, Hille D, Furst KW, Dain MP, VandePol C, Skarinsky D.
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):7-12. PubMed ID: 10649149
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Efficacy and tolerability of a new 7-day transdermal estradiol patch versus placebo in hysterectomized women with postmenopausal complaints.
    von Holst T, Salbach B.
    Maturitas; 2000 Feb 15; 34(2):143-53. PubMed ID: 10714909
    [Abstract] [Full Text] [Related]

  • 58. Relief of hot flushes with new plant-derived 10-component synthetic conjugated estrogens.
    Utian WH, Lederman SA, Williams BM, Vega RY, Koltun WD, Leonard TW.
    Obstet Gynecol; 2004 Feb 15; 103(2):245-53. PubMed ID: 14754691
    [Abstract] [Full Text] [Related]

  • 59. Transition to raloxifene with and without low-dose estrogen therapy in postmenopausal women: effects on serum lipids and fibrinogen - a pilot study.
    O'Neill SM, Eden J, Baber R, Ekangaki A, Stocks JM, Wolthers T, Davis SR.
    Climacteric; 2003 Dec 15; 6(4):347-53. PubMed ID: 15006256
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.